BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
New BD FACSDiscover™ A8 cell analyzer brings leading-edge capabilities to wider range of scientists across academia and biopharma
May 13, 2025
BD SpectralFX™ Technology maximizes the number of colors that can be used in flow cytometry, allowing scientists to perform deep immunophenotyping of biological samples to pursue novel biomarker discovery using panels of more than 50 fluorescent reagents at a time, with optimal resolution and sensitivity. Further, BD CellView™ Image Technology enables high-speed fluorescent and label-free imaging of single cells, revealing precise spatial and morphological insights – like the location of a virus or protein within a single cell, or the microscopic interaction occurring between two cells – that can be visually confirmed and analyzed in real time.
Combining these technologies, which were first introduced in the BD FACSDiscover™ S8 Cell Sorter and profiled on the cover of the journal Science, the BD FACSDiscover™ A8 Cell Analyzer enables the measurement of an unprecedented number of characteristics from cells with exceptional depth, speed and sensitivity, allowing scientists to capture more insights per experiment than ever before.
Additional advancements on the BD FACSDiscover™ A8 Cell Analyzer are specifically designed to power translational research.
Highlights include:
- High-throughput, walkaway automation that enables best-in-class cost-per-insight economics
- New intuitive software workflows that allow for effective management of large datasets, for improved system usability
- Seamless pairing with the industry-leading ecosystem of BD FACSDiscover™ Cell Sorters and BD Reagents
"The BD FACSDiscover™ A8 Cell Analyzer signals an exciting step forward for researchers in areas like immuno-oncology that require tools delivering excellent reproducibility and performance, while managing budget constraints,” said Rui Gardner, head of Flow Cytometry Core Facility at Memorial Sloan Kettering Cancer Center, an early access collaboration site. "Our investigators have already learned so much using this new technology, and we look forward to performing deep immunophenotyping for high-fidelity biomarker discovery to elucidate insights that can advance research and improve human health.”
Steve Conly, worldwide president of BD Biosciences, added, “Translational research, in particular, is growing at a rapid pace and the BD FACSDiscover™ A8 Cell Analyzer combines advanced science with ease of use to empower, like never before, scientists developing the next generation of potentially life-changing therapies. Paired with the BD FACSDiscover™ S8 Cell Sorter, and alongside our advancements in software, informatics, and reagents, this landmark cell analyzer will enable new dimensions of possibilities in one state-of-the-art ecosystem.”
New software innovations launching alongside the instrument include the latest version of BD FACSChorus™ Software, which simplifies workflows on both the BD FACSDiscover™ A8 Cell Analyzer as well as FACSDiscover™ S8 Cell Sorter, and the faster, easier-to-use analysis software FlowJo v11. All three products will be featured at the International Society for Advancement of Cytometry CYTO 2025 event at booth 615 from May 31 to June 4 in Denver.
The BD FACSDiscover™ A8 Cell Analyzer is now available to order through local sales representatives.